EP3595727
LIPID NANOPARTICLE FORMULATION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
15.3.2018EP published:
27.11.2024EP application number:
18715417.4
EPO information:
European Patent Register
Max expiry date:
14.3.2038
Title in English:
LIPID NANOPARTICLE FORMULATIONLanguage of the patent:
English
Timeline
Today
15.3.2018EP application
27.11.2024EP Publication
Owner
Name:
ModernaTX, Inc.Address:
325 Binney Street, Cambridge, MA 02142, US
Name:
Oregon State UniversityAddress:
A312 Kerr Administration Building, Corvallis, OR 97331, US
Inventor
Name:
PATEL, SiddharthAddress:
Corvallis Oregon 97331, US
Name:
ROBINSON, EmilyAddress:
Corvallis Oregon 97331, US
Name:
BROWN, AnnaAddress:
Corvallis Oregon 97331, US
Name:
ALMARSSON, OrnAddress:
Cambridge Massachusetts 02139, US
Name:
BENENATO, Kerry E.Address:
Cambridge Massachusetts 02139, US
Name:
SABNIS, StaciAddress:
Cambridge Massachusetts 02139, US
Name:
SAHAY, GauravAddress:
Portland Oregon 97229, US
Name:
NARAYANA, Ashwani KumarAddress:
Portland Oregon 97239, US
Priority
Number:
201762471949 PDate:
15.3.2017Country:
US
Number:
201762475166 PDate:
22.3.2017Country:
US
Classification
Categories:
A61K 9/00, A61K 9/08, A61K 9/51, A61K 31/7105, A61K 47/24, A61K 9/127, A61K 47/14, A61K 47/28